Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
On behalf of the Dutch-Belgian Mycosis study group
Research output: Contribution to journal › Article › peer-review
10Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B'. Together they form a unique fingerprint.